Neurotrope Bioscience, Inc. Employee Directory
PharmaceuticalsNew York, United States2-10 Employees
Neurotrope BioScience is a small New York–based biotechnology company focused on developing Bryostatin-1–based therapies for neurodegenerative diseases and developmental disorders, with an initial emphasis on Alzheimer’s disease. Formed in 2012, it maintains a pipeline targeting serious and orphan conditions such as Fragile X Syndrome and Niemann-Pick Type C, exploring multiple therapeutic approaches. Its work centers on modulating neuronal signaling and amyloid pathways to support synaptic function and potentially reduce neurotoxic processes.